## Impact Classification

Clinical follow-up packet for PR 497, prepared source `4c85fdf5a97eea10c8efcc6d105cd32de054e030` based on remote `f26625a12bba1052da5b9af88bad88c1bf12420c`. The UI change, its real isolated concurrency proof, and fresh browser proof are documented with their exact evidence boundaries. This candidate has not been published.

## Current Behaviour

Claude 2 comment 6330482468 requested two UI fixes and real PostgreSQL concurrency evidence. UI15 passed its local suite but independent review found a severe allergy text contrast regression; that failed review remains preserved. UI16 corrected the contrast issue, passed independent review and negative controls, and the final integrated UI source then passed fresh browser verification on actual app and component paths. The concurrency proof ran against `f26625a12bba1052da5b9af88bad88c1bf12420c`; its backend bytes are identical to the prepared source.

## Expected Behaviour

Regular and severe allergy text remains readable on their existing colored backgrounds. A supervisor can explicitly confirm a pending dose, which creates one durable administration record and survives reload. A load failure fails closed without actions or writes. Filtered confirmation behavior is verified separately with a production React component fixture; this fixture is synthetic and makes no clinical API requests.

The backend concurrency scenario observes a real Assistant Tool HTTP writer blocked by a transaction holding the patient row. PostgreSQL reports SQLSTATE 40001 and the endpoint returns HTTP 409 without clinical writes. An unlocked positive control returns HTTP 200 and writes one dose. Two forged import forms are rejected atomically. This is not a full natural-language or `executeSkill` retry proof.

## Acceptance Criteria

UI author evidence: 1,550 frontend tests and frontend typecheck passed. Independent UI16 evidence: 33 focused tests, typecheck, independent contrast analysis, and both UI15-negative checks passed. Fresh browser runtime5 on source `4c85fdf5a97eea10c8efcc6d105cd32de054e030` passed: 12 measured contrast groups with minimum 14.380:1, actual confirmation HTTP 200 with exactly one owned SQL administration and reload persistence, and scoped 503 fail-closed behavior without writes. Component fixture: one allowed callback, zero blocked callbacks, and no non-asset HTTP requests. This component result is not clinical HTTP/PG E2E.

The original eight `bb12` clinical/browser proof aliases remain unchanged; they were not rerun as a new eight-case suite on source `4c85`. Current publication-head native checks, a new actual Claude review, final Codex review, deployment, and closure remain pending.

## Test Plan

No tests or runtime actions are performed while assembling this candidate. The included results are attributed to the source-bound author, independent QA, concurrency runtime2, and browser runtime5 receipts. Browser runtime5 records build, migration, fixture, app, and component steps exiting successfully; media hashes are checked against its actual output manifest. Runtime1 through runtime4 failures and partial attempts remain failed historical evidence and are not relabeled.

## Evidence Plan

`browser/app/` and `browser/component/` contain only allowlisted `results.json`, `trace-privacy.json`, `ffprobe.json`, screenshots, finalized video, and sanitized trace archives verified byte-for-byte against runtime5's manifest. Raw private traces, process/environment payloads, Docker inspection, and full runtime seals are excluded. `source-provenance.json`, `input-provenance.json`, `browser-input-manifest.json`, and `payload-inventory.json` bind the selected evidence and source. `public-payload-seal.json` covers the exact candidate files other than itself.

## Gate Status

READY FOR IMPLEMENTATION of root-owned independent candidate QA and publication preparation. This candidate is not a publication, native-check approval, Claude/Codex approval, deployment, or issue closure. Those gates remain pending.
